10.86MMarket Cap-266P/E (TTM)
7.7700High6.5600Low25.98KVolume7.1700Open7.2000Pre Close186.86KTurnover4.24%Turnover RatioLossP/E (Static)1.58MShares83.769052wk High7.65P/B4.20MFloat Cap4.432052wk Low--Dividend TTM612.33KShs Float2568.3000Historical High--Div YieldTTM16.81%Amplitude4.4320Historical Low7.1920Avg Price1Lot Size
Vaccinex Stock Forum
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
Vaccinex announced the completion of the last patient visit in its Phase 1b/2 SIGNAL-AD study of pepinemab for Alzheimer's Disease (AD). The database lock is expected in June, with key outcomes to be reported in July.
Pepinemab targets astrocyte reactivity and neuroinflammation, believed to accelerate AD progression. Key endpoints incl...
Anybody have some idea or clue as to the runnings on these docs so when you do come in please, can you include your best entry and exit strategies on the stock
$ParaZero Technologies(PRZO.US)$ 1.02 loading hit 1.7
$Molekule Group(MKUL.US)$ 0.13 loading hit 0.158
$Acurx Pharmaceuticals(ACXP.US)$ 1.2 loading hit 1.94
No comment yet